Tradewind BioScience
Company

Tradewind BioScience

Biotechnology San Francisco Bay Area, United States 5 employees
Employees
5
Contacts
2
Emails
2

Tradewind BioScience Overview

Headquarters
San Francisco Bay Area, United States
Industry
Biotechnology
Employees
5
Founded
2018
Funding
120.0K

About Tradewind BioScience

Tradewind is dedicated to creating therapeutics for the most aggressive, difficult to treat cancers. Our lead program is a high-affinity, multifaceted attack antibody for cancer that functions through the inhibition of a novel, but validated, target protein. Tradewind’s first-in-class lead program operates through multiple modes of action - directly on cancer cells, and through the immune system, with both mechanisms of attack substantiated by in vivo studies. We can target the primary cancer, metastatic tumors, and even stop metastasis from spreading further. Our mission is to develop only transformative medicines that will have a significant impact on patient outcomes. Tradewind’s drug development is paired with a focus on biomarker identification, ensuring that our therapeutics will benefit the patients for whom it is most meaningful. The lead program is expected to be a game-changer for ovarian cancer, followed by other indications. Tradewind is backed by Y Combinator and the National Cancer Institute (NCI) to advance its innovative approach to fighting cancer.

Tradewind BioScience Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

Tradewind BioScience Org Chart

Sample employees and titles
Name Title Contact
Frans Trouwen
Email
Thaddeus Allen, Phd, PMP Business Development - Scientist
View
Jack Doty Chief Executive Officer and Chairman
View
Melanie Finlayson Corporate Development - Capital Markets
Email

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile

Compare Similar Companies to Tradewind BioScience